This is in contrast to antipyschotics such as olanzapine, which bind strongly to a range of neurotransmitter receptors. Although the effects of LY2140023 in the long term, its optimal dosage and ...

This suggests that olanzapine could be a valuable addition ... Additionally, a head-to-head study comparing two neurokinin-1 receptor antagonists, fosnetupitant and fosaprepitant, found that ...

Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...

Am J Health Syst Pharm. 2008;65(12):1180-1183. Ultimately, more formalized, high-quality, and clinically applicable studies are necessary to determine the safety of the parenteral combination of ...

Olanzapine is an atypical antipsychotic and ... to the schizophrenia treatment landscape by targeting cholinergic receptors ...